1h Free Analyst Time
The microfluidics technology market is forecasted to grow by USD 31.47 billion during 2023-2028, accelerating at a CAGR of 20.28% during the forecast period. The report on the microfluidics technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing applications in molecular biology, advances in DNA sequencing increases use of microfluidic techniques, and rise in cancer incidences demands novel methods of diagnosis and drug delivery.
The microfluidics technology market is segmented as below:
By Material
- Polymer-based microfluidics
- Glass-based microfluidics
- Silicon-based microfluidics
- Others
By End-user
- Hospitals
- Diagnostic centers
- Academic institutes
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the microfluidics technology market covers the following areas:
- Microfluidics technology market sizing
- Microfluidics technology market forecast
- Microfluidics technology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The company presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Material
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global microfluidics technology market: Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biocartis NV, BioFluidix GmbH, Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Epigem Ltd., F. Hoffmann La Roche Ltd., Fluigent SA, iBiochips, IDEX Corp., Illumina Inc., Perkin Elmer Inc., QIAGEN NV, SMC Corp., Standard BioTools Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing use of microfluidics technology in cosmetics."
According to the report, one of the major drivers for this market is the increasing applications in molecular biology.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Biocartis NV
- BioFluidix GmbH
- Blacktrace Holdings Ltd.
- Cellix Ltd.
- Danaher Corp.
- Elveflow
- Epigem Ltd.
- F. Hoffmann La Roche Ltd.
- Fluigent SA
- iBiochips
- IDEX Corp.
- Illumina Inc.
- Perkin Elmer Inc.
- QIAGEN NV
- SMC Corp.
- Standard BioTools Inc.
- Thermo Fisher Scientific Inc.
